Pro-inflammatory mediators and apoptosis correlate to rt-PA response in a novel mouse model of thromboembolic stroke

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Ansar, Saema ^a   Chatzikonstantinou, Eva ^a   Thiagarajah, Rushani ^a   Tritschler, Laurent ^a   Fatar, Marc ^a   Hennerici, Michael G ^a   Meairs, Stephen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CASPASE 3; GELATINASE B; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; FIBRINOLYTIC AGENT; HEAT SHOCK PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOLOGY; IMMUNOFLUORESCENCE; MALE; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECANALIZATION; ANIMAL; APOPTOSIS; BRAIN; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; STROKE; THROMBOEMBOLISM;

ANIMALS; APOPTOSIS; BRAIN; CASPASE 3; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; HEAT-SHOCK PROTEINS; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; STROKE; THROMBOEMBOLISM; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84919735045     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085849     Document Type: Article

References (31)

1. Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17: 796-808.
2. Lakhan SE, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7: 97.
3. Muir KW, Tyrrell P, Sattar N, Warburton E (2007) Inflammation and ischaemic stroke. Curr Opin Neurol 20: 334-342. (Pubitemid 46743118)
4. Candelario-Jalil E, Yang Y, Rosenberg GA (2009) Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158: 983-994.
5. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT (2009) Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 276: 13-26.
6. Minami M, Satoh M (2003) Chemokines and their receptors in the brain: pathophysiological roles in ischemic brain injury. Life Sci 74: 321-327. (Pubitemid 37357063)
7. Rosell A, Ortega-Aznar A, Alvarez-Sabin J, Fernandez-Cadenas I, Ribo M et al. (2006) Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 37: 1399-1406. (Pubitemid 44305716)
8. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A et al. (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359: 1317-1329.
9. Wahlgren N, Ahmed N, Davalos A, Hacke W, Millan M et al. (2008) Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 372: 1303-1309.
10. Hacke W, Donnan G, Fieschi C, Kaste M, von KR et al. (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363: 768-774.
11. Saver JL (2011) Improving reperfusion therapy for acute ischaemic stroke. J Thromb Haemost 9 Suppl 1: 333-343.
12. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ et al. (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32: 78-86.
13. Kablau M, Alonso A, Hennerici MG, Fatar M (2012) Treatment with tPA predicts better outcome even if MCA occlusion persists. Int J Stroke.
14. Orset C, Macrez R, Young AR, Panthou D, Angles-Cano E et al. (2007) Mouse model of in situ thromboembolic stroke and reperfusion. Stroke 38: 2771-2778. (Pubitemid 47494017)
15. Langhauser FL, Heiler PM, Grudzenski S, Lemke A, Alonso A et al. (2012) Thromboembolic stroke in C57BL/6 mice monitored by 9.4 T MRI using a 1H cryo probe. Exp Transl Stroke Med 4: 18.
16. Vogel J, Mobius C, Kuschinsky W (1999) Early delineation of ischemic tissue in rat brain cryosections by high-contrast staining. Stroke 30: 1134-1141. (Pubitemid 29211638)
17. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C et al. (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10: 290-293. (Pubitemid 20096202)
18. Li F, Liu KF, Silva MD, Omae T, Sotak CH et al. (2000) Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats: correlation with histopathology. Stroke 31: 946-954. (Pubitemid 30198444)
19. Sicard KM, Henninger N, Fisher M, Duong TQ, Ferris CF (2006) Long-term changes of functional MRI-based brain function, behavioral status, and histopathology after transient focal cerebral ischemia in rats. Stroke 37: 2593-2600. (Pubitemid 44454684)
20. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516.
21. Nedelmann M, Ritschel N, Doenges S, Langheinrich AC, Acker T et al. (2010) Combined contrast-enhanced ultrasound and rt-PA treatment is safe and improves impaired microcirculation after reperfusion of middle cerebral artery occlusion. J Cereb Blood Flow Metab 30: 1712-1720.
22. Dawson DA, Ruetzler CA, Hallenbeck JM (1997) Temporal impairment of microcirculatory perfusion following focal cerebral ischemia in the spontaneously hypertensive rat. Brain Res 749: 200-208. (Pubitemid 27104200)
23. Okada Y, Copeland BR, Fitridge R, Koziol JA, del Zoppo GJ (1994) Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke 25: 1847-1853.
24. Garcia-Yebenes I, Sobrado M, Zarruk JG, Castellanos M, Perez de la Ossa N et al. (2011) A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke. Stroke 42: 196-203.
25. Alexandrov AV, Grotta JC (2002) Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 59: 862-867.
26. Vivien D, Gauberti M, Montagne A, Defer G, Touze E (2011) Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence. J Cereb Blood Flow Metab 31: 2119-2134.
27. Yepes M, Roussel BD, Ali C, Vivien D (2009) Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci 32: 48-55.
28. Lo EH, Wang X, Cuzner ML (2002) Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 69: 1-9. (Pubitemid 34734159)
29. Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS et al. (2005) Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol 289: H558-H568. (Pubitemid 41129369)
30. Pfeuffer J, Adriany G, Shmuel A, Yacoub E, Van de Moortele PF et al. (2002) Perfusion-based high-resolution functional imaging in the human brain at 7 Tesla. Magn Reson Med 47: 903-911.
31. Langheinrich AC, Michniewicz A, Bohle RM, Ritman EL (2007) Vasa vasorum neovascularization and lesion distribution among different vascular beds in ApoE2/2/LDL2/2 double knockout mice. Atherosclerosis 191: 73-81. (Pubitemid 46227431)